Laboratory diagnosis of factor XIII deficiency, routine coagulation tests with quantitative and qualitative methods

Clinical Laboratory

Volumn 62, Issue 4, 2016, Pages 491-498

  Dorgalaleh, Akbar ^a   Kazemi, Ahmad ^a   Zaker, Farhad ^e   Shamsizadeh, Morteza ^b   Rashidpanah, Jamal ^c   Mollaei, Mojtaba ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coagulation tests; Factor XIII deficiency; Laboratory diagnosis

Indexed keywords

BLOOD CLOTTING FACTOR 13; SOLUBILIZER;

BLEEDING TIME; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD SAMPLING; BLOOD STORAGE; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; PUBLICATION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBIN TIME; THROMBOCYTE COUNT; FACTOR XIII DEFICIENCY; PROCEDURES;

BLOOD COAGULATION TESTS; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; FACTOR XIII DEFICIENCY; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME;

EID: 84971482938     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.150619     Document Type: Review

References (63)

1. Naderi M, Dorgalaleh A, Tabibian S, Alizadeh S, Eshghi P, Solaimani G. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol. 2013; 3(4): 164-72.
2. Anwar R, Miloszewski KJ. Factor XIII deficiency. Br J Haema-tol. 1999;107(3):468-84.
3. Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona É. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011;91(3):931-72.
4. Komáromi I, Bagoly Z, Muszbek L. Factor XIII: novel structural and functional aspects. J Thromb Haemost. 2011;9(1):9-20.
5. Dorgalaleh A, Naderi M, Hosseini MS, et al. Factor XIII Deficiency in Iran: A Comprehensive Review of the Literature. Seminars in Thrombosis and Hemostasis (No. EFirst), Thieme Medical Publishers.
6. Lawrie A, Green L, Mackie I, Liesner R, Machin S, Peyvandi F. Factor XHI-an under diagnosed deficiency-are we using the right assays? J Thromb Haemost. 2010;8(11):2478-82.
7. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood. 2003; 102(13):4410-2.
8. Asahina T, Kobayashi T, Okada Y, Goto J, Terao T. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta. 2000;21(4):388-93.
9. Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogen-esis. J Thromb Haemost. 2006 Jan;4(1): 19-25.
10. Nahrendorf M, Hu K, Frantz S, et al. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation. 2006;113(9):1196-202.
11. Naderi M, Eshghi P, Saneei Moghaddam E, Alizadeh S, Dorgalaleh A, Younesi M, et al. Safety of human blood products in rare bleeding disorders in southeast of Iran. Haemophilia. 2013;19(2):e90-e2.
12. Naderi M, Tabibian S, Hosseini MS, et al. Rare bleeding disorders: a narrative review of epidemiology, molecular and clinical presentations, diagnosis and treatment. Journal of Pediatrics Review. 2014;2(2).
13. Inbal A, Oldenburg J, Carcao M, Rosholm A, Tehranchi R, Nugent D. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood. 2012;119(22):51 11-7.
14. Peyvandi F, Di Michele D, Bolton-Maggs P, Lee C, Tripodi A, Srivastava A. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost. 2012 Sep;10(9): 1938-43.
15. Britten AF. Congenital deficiency of factor XIII (fibrin-stabilizing factor): Report of a case and review of the literature. Am J Med. 1967 Nov;43(5):751-61.
16. Ribizzi G, Farinini D, Gentile R, Rizzi D, Serrati C. Factor XIII deficiency and head trauma: management and therapy. Neurol Sci.2015Oct;36(10):1933-4.
17. Bertamino M, Banov L, Molinari AC. Diagnosis and management of severe congenital factor XIII deficiency in the Emergency Department: lessons from a "model" family. Blood Transfus. 2015Apr;13(2):324-7.
18. Dorgalaleh A, Farshi Y, Alizadeh S, et al. Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran. J Thromb Haemost. 2015Sep;13(9):1735-6.
19. Poudyal BS, Shrestha GS. Factor XIII deficiency: the first case reported from Nepal. The Egyptian Journal of Haematology. 2015;40(3):148.
20. El Rassy E, Kourie HR, Antoun J, Chouery E, Megarbane A, Nasr F. Factor XIII deficiency revealed by spontaneous intramed-ullary hemorrhage: confirmation of a severe mutation. Blood Co-agul Fibrinolysis. 2015 Jul;26(5):586-7.
21. Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M. Guidelines on the laboratory aspects of assays used in haemosta-sis and thrombosis. Int J Lab Hematol. 2013 Feb;35(1):1-13.
22. Anwar R, Stewart AD, Miloszewski KJ, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol. 1995Nov;91(3):728-35.
23. Favaloro EJ, Funk DMA, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab Medicine. 2012;43(2):1-10.
24. Kratz A, Stanganelli N, Van Cott EM. A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive study. Arch Pathol Lab Med. 2006; 130(1):39-44.
25. Castellone D. How to deliver quality results in the coagulation laboratory: commonly asked questions. Lab Medicine. 2004; 35(4):208-13.
26. Cengiz M, Ulker P, Meiselman HJ, Baskurt OK. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythro-cyte mechanical properties. Clin Chem Lab Med. 2009;47(6): 769-76.
27. Salvagno GL, Lippi G, Bassi A, Poli G, Guidi GC. Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory. Journal of evaluation in clinical practice. 2008;14(2):351-3.
28. Preston F, Lippi G, Favaloro E, Jayandharan G, Edison E, Srivastava A. Quality issues in laboratory haemostasis. Haemophilia. 2010 Jul;16 Suppl 5:93-9.
29. Potgieter JJ, Pool R, Prinsloo A, Botha EM, Olorunju S. The impact of collection tube fill volume on international normalized ratio: peer reviewed original article. Medical Technology SA. 2010; 24(1): 11-6.
30. Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ, editors. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost. 2012 Sep;38(6): 565-75.
31. Lawrence JB. Preanalytical variables in the coagulation laboratory. Lab Medicine. 2003;34(1):49-57.
32. Organization WH. WHO guidelines on drawing blood: best practices in phlebotomy. 2010.
33. Lippi G, Bassi A, Brocco G, Montagnana M, Salvagno GL, Guidi GC. Preanalytic error tracking in a laboratory medicine department: results of a 1-year experience. Clinical Chemistry. 2006; 52(7): 1442-3.
34. Design E. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med. 2006;130:181-4.
35. Salvagno G, Lippi G, Montagnana M, Franchini M, Poli G, Guidi G. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol. 2009;31(4):462-7.
36. Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M. Guidelines on the laboratory aspects of assays used in haemosta-sis and thrombosis. Int J Lab Hematol. 2013;35(1):1-13.
37. Laga AC, Cheves TA, Sweeney JD. The effect of specimen he-molysis on coagulation test results. Am J Clin Pathol. 2006; 126(5):748-55.
38. Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. Blood coagulation and fibrinolysis in relation to degree of physical activity during work and leisure time. Acta Med Scand. 1973;193(1-6):73-7.
39. Bourey RE, Santoro SA. Interactions of exercise, coagulation, platelets, and fibrinolysis-a brief review. Med Sci Sports Exerc. 1988;20(5):439-46.
40. Blombäck M, Konkle B, Manco-Johnson M, Bremme K, Hellgren M, Kaaja R. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost. 2007;5(4):855-8.
41. Upreti S, Upreti S, Bansal R, Jeelani N, Bharat V. Types and Frequency of Preanalytical Errors in Haematology Lab. Journal of clinical and diagnostic research: JCDR. 2013;7(11):2491.
42. Lippi G, Buonocore R, Musa R, Ippolito L, Picanza A, Favaloro E. The effect of hyperglycaemia on haemostasis testing-a volunteer study. Anaesthesia. 2015;70(5):549-54.
43. Jennings I, Kitchen S, Woods T, Preston F. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost. 2003;1(12):2603-8.
44. Borhany M, Shamsi T, Moiz B, et al. Guidelines on the laboratory diagnosis of congenital bleeding disorders in Pakistan. JPMA The Journal of the Pakistan Medical Association. 2012;62(5): 477-86.
45. Gregory TF, Cooper B. Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent). 2006;19(3):221.
46. Lillicrap D, Nair S, Srivastava A, Rodeghiero F, Pabinger I, Federici A. Laboratory issues in bleeding disorders. Haemophilia. 2006;12(s3):68-75.
47. Tripodi A, Caldwell S, Hoffman M, Trotter J, Sanyal A. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther. 2007; 26(2): 141-8.
48. Kamal AH, Tefferi A, Pruthi RK, editors. How to interpret and pursue an abnormal prothrombin time, activated partial thrombo-plastin time, and bleeding time in adults. Mayo Clin Proc. 2007 Jul;82(7):864-73.
49. Horsti J, Uppa H, Vilpo JA. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. Clin Chem. 2005;51(3):553-60.
50. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Man-nucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. 2004; 104(12):3631-4.
51. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol. 2007;73(7/8):401.
52. Philipp C, Miller C, Faiz A, et al. Screening women with menor-rhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time. Haemophilia. 2005;11(5): 497-503.
53. Michelson AD, Frelinger AL, Furman MI. Current options in platelet function testing. The American journal of cardiology. 2006;98(10):S4-S10.
54. Yardumian D, Mackie I, Machin S. Laboratory investigation of platelet function: a review of methodology. J Clin Pathol. 1986; 39(7):701-12.
55. Harrison P. Platelet function analysis. Blood Rev. 2005;19(2): 111-23.
56. Marchant K, Corcoran G. The laboratory diagnosis of platelet disorders. An algorithmic approach. Arch Pathol Lab Med. 2002; 126:133-46.
57. Dorgalaleh A, Tabibian S, Hosseini S, Shamsizadeh M. Guidelines for laboratory diagnosis of factor XIII deficiency. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis. 2015, DOI:10.1097/MBC.0000000000000459.
58. Ajzner E, Muszbek L. Kinetic spectrophotometric factor XIII activity assays: the subtraction of plasma blank is not omissible [corrected]. Journal of thrombosis and haemostasis: JTH. 2004; 2(11):2075.
59. Oertel K, Hunfeld A, Specker E, et al. A highly sensitive fluo-rometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem. 2007;367(2): 152-8.
60. Hsu P, Zantek ND, Meijer P, et al. editors. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results. Semin Thromb Hemost; 2014, 40(2):232-238.
61. Yorifuji H, Anderson K, Lynch GW, Van De Water L, McDonagh J. B protein of factor XIII: differentiation between free B and complexed B. Blood, 1988;72(5): 1645-50.
62. Katona É, Haramura G, Kárpáti L, Fachet J, Muszbek L. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A 2 B 2). Thromb Haemost. 2000;83(2): 268-73.
63. Katona É, Ajzner É, Tóth K, Kárpáti L, Muszbek L. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods. 2001;258(1):127-35.